Summary of Study ST002980
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001856. The data can be accessed directly via it's Project DOI: 10.21228/M8T42G This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002980 |
Study Title | Water soluble metabolomics in mice upon loss of SHMT |
Study Summary | The enzyme SHMT interconverts the amino acids serine and glycine as part of the folate cycle. To explore the role of SHMT in amino acid homeostasis, Mice were treated with a small molecule inhibitor of SHMT (SHIN2) or had Shmt2 genetically knocked-out in a liver specific manner. Serum and liver samples were collected and underwent LC-MS metabolomics analysis. |
Institute | Princeton University |
Last Name | McBride |
First Name | Matthew |
Address | Carl Icahn Lab, South Drive, Princeton, NJ 08544 |
matthewmcbride@princeton.edu | |
Phone | 8567457389 |
Submit Date | 2023-11-14 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzXML |
Analysis Type Detail | LC-MS |
Release Date | 2023-12-12 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001856 |
Project DOI: | doi: 10.21228/M8T42G |
Project Title: | Glycine homeostasis requires reverse SHMT flux |
Project Type: | LCMS metabolomics |
Project Summary: | The folate-dependent enzyme serine hydroxymethyltransferase (SHMT) reversibly converts serine into glycine and a tetrahydrofolate-bound one-carbon unit. Such one-carbon unit production plays a critical role in development, the immune system, and cancer. Using rodent models, here we show that the whole-body SHMT flux acts to net consume rather than produce glycine. Pharmacological inhibition of whole-body SHMT1/2 and genetic knockout of liver SHMT2 elevated circulating glycine levels up to eight-fold. Stable isotope tracing revealed that the liver converts glycine to serine, which is then converted by serine dehydratase into pyruvate and burned in the tricarboxylic acid cycle. In response to diets deficient in serine and glycine, de novo biosynthetic flux was unaltered but SHMT2- and serine dehydratase-mediated catabolic flux was lower. Thus, glucose-derived serine synthesis does not respond to systemic demand. Instead, circulating serine and glycine homeostasis is maintained through variable consumption, with liver SHMT2 a major glycine-consuming enzyme. |
Institute: | Princeton University |
Department: | Department of Chemistry |
Laboratory: | Josh Rabinowitz |
Last Name: | McBride |
First Name: | Matthew |
Address: | Carl Icahn Lab, South Drive, Princeton, NJ 08544 |
Email: | matthewmcbride@princeton.edu |
Phone: | 8567457389 |
Subject:
Subject ID: | SU003093 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Species Group: | Mammals |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample type | Genotype | Treatment |
---|---|---|---|---|
SA323395 | SHMT2flox_KO_22_liver | Liver | Liver KO | None |
SA323396 | SHMT2flox_KO_23_liver | Liver | Liver KO | None |
SA323397 | SHMT2flox_KO_21_liver | Liver | Liver KO | None |
SA323398 | SHMT2flox_KO_35_liver | Liver | Liver KO | None |
SA323399 | SHMT2flox_KO_43_liver | Liver | Liver KO | None |
SA323400 | SHMT2flox_KO_45_liver | Liver | Liver KO | None |
SA323401 | SHMT2flox_KO_44_liver | Liver | Liver KO | None |
SA323402 | SHMT2flox_WT_46_liver | Liver | Wild-type | None |
SA323403 | SHMT2flox_WT_15_liver | Liver | Wild-type | None |
SA323404 | SHMT2flox_WT_20_liver | Liver | Wild-type | None |
SA323405 | SHMT2flox_WT_34_liver | Liver | Wild-type | None |
SA323406 | SHMT2flox_WT_37_liver | Liver | Wild-type | None |
SA323407 | SHIN2_2_liver | Liver | Wild-type | SHIN2 |
SA323408 | SHIN2_3_liver | Liver | Wild-type | SHIN2 |
SA323409 | SHIN2_1_liver | Liver | Wild-type | SHIN2 |
SA323410 | Veh_1_liver | Liver | Wild-type | Vehicle |
SA323411 | Veh_2_liver | Liver | Wild-type | Vehicle |
SA323412 | Veh_3_liver | Liver | Wild-type | Vehicle |
SA323413 | SHMT2flox_KO_45_serum | Serum | Liver KO | None |
SA323414 | SHMT2flox_KO_44_serum | Serum | Liver KO | None |
SA323415 | SHMT2flox_KO_22_serum | Serum | Liver KO | None |
SA323416 | SHMT2flox_KO_21_serum | Serum | Liver KO | None |
SA323417 | SHMT2flox_KO_43_serum | Serum | Liver KO | None |
SA323418 | SHMT2flox_KO_23_serum | Serum | Liver KO | None |
SA323419 | SHMT2flox_KO_35_serum | Serum | Liver KO | None |
SA323420 | SHMT2flox_WT_20_serum | Serum | Wild-type | None |
SA323421 | SHMT2flox_WT_15_serum | Serum | Wild-type | None |
SA323422 | SHMT2flox_WT_34_serum | Serum | Wild-type | None |
SA323423 | SHMT2flox_WT_37_serum | Serum | Wild-type | None |
SA323424 | SHMT2flox_WT_46_serum | Serum | Wild-type | None |
SA323425 | SHIN2_2_serum | Serum | Wild-type | SHIN2 |
SA323426 | SHIN2_1_serum | Serum | Wild-type | SHIN2 |
SA323427 | SHIN2_3_serum | Serum | Wild-type | SHIN2 |
SA323428 | Veh_2_serum | Serum | Wild-type | Vehicle |
SA323429 | Veh_3_serum | Serum | Wild-type | Vehicle |
SA323430 | Veh_1_serum | Serum | Wild-type | Vehicle |
Showing results 1 to 36 of 36 |
Collection:
Collection ID: | CO003086 |
Collection Summary: | For pharmacological inhibition of SHMT, mice were treated with Vehicle or SHIN2 for 12 hours and then blood serum and liver samples were collected. For genetic loss of Shmt2, blood serum and liver samples were collected from mice 21 days after liver-specific gene knockout. |
Sample Type: | Blood (serum) and Liver |
Treatment:
Treatment ID: | TR003102 |
Treatment Summary: | For pharmacological inhibition of SHMT, mice (C57BL/6N) were divided into two groups and received Vehicle (20% 2-hydroxypropyl-β-cyclodextrin) or SHIN2 (200 mg/kg) for 12 hours. For genetic loss of Shmt2, Shmt2(flox/flox) mice and wild-type litter mate controls were injected with AAV8-TBG-Cre viral particles to induce liver-specific gene knockout and samples were harvested 21 days later. |
Sample Preparation:
Sampleprep ID: | SP003099 |
Sampleprep Summary: | Water soluble metabolites were extracted from serum and liver samples. 3ul of serum was extracted with 120 ul (40X) of 100% methanol, cooled on ice for 10 minutes, centrifuged at 16,000 x g for 30 minutes, and supernatant collected. 20mg of ground liver tissue was extracted with 800ul of 40:40:20 methanol:acetonitrile:water, cooled on ice for 10 minutes, centrifuged at 16,000 x g for 30 minutes, and supernatant collected. |
Combined analysis:
Analysis ID | AN004897 | AN004898 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | HILIC | HILIC |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Waters XBridge BEH Amide (100 x 2.1mm,2.5um) | Waters XBridge BEH Amide (100 x 2.1mm,2.5um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive Plus Orbitrap | Thermo Q Exactive Plus Orbitrap |
Ion Mode | NEGATIVE | POSITIVE |
Units | Peak area | Peak area |
Chromatography:
Chromatography ID: | CH003695 |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters XBridge BEH Amide (100 x 2.1mm,2.5um) |
Column Temperature: | 25°C |
Flow Gradient: | 0 minutes, 85% B; 2 minutes, 85% B; 3 minutes, 80% B; 5 minutes, 80% B; 6 minutes, 75% B; 7 minutes, 75% B; 8 minutes, 70% B; 9 minutes, 70% B; 10 minutes, 50% B; 12 minutes, 50% B; 13 minutes, 25% B; 16 minutes, 25% B; 18 minutes, 0% B; 23 minutes, 0% B; 24 minutes, 85% B; 30 minutes, 85% B |
Flow Rate: | 150 μl/min |
Solvent A: | 95% water/5% acetonitrile with 20 mM ammonium acetate, 20 mM ammonium hydroxide, pH 9.4 |
Solvent B: | 100% acetonitrile |
Chromatography Type: | HILIC |
MS:
MS ID: | MS004641 |
Analysis ID: | AN004897 |
Instrument Name: | Thermo Q Exactive Plus Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | MS full scans were in negative ion mode with a resolution of 140,000 at m/z 200 and scan range of 70–1,000 m/z. The automatic gain control (AGC) target was 1 × 10^6. LC-MS peak files were analyzed and visualized with El-MAVEN (Elucidata) using 5 ppm ion extraction window, minimum peak intensity of 1 x 10^5 ions, and minimum signal to background blank ratio of 2. |
Ion Mode: | NEGATIVE |
MS ID: | MS004642 |
Analysis ID: | AN004898 |
Instrument Name: | Thermo Q Exactive Plus Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | MS full scans were in positive ion mode with a resolution of 140,000 at m/z 200 and scan range of 70–1,000 m/z. The automatic gain control (AGC) target was 1 × 10^6. LC-MS peak files were analyzed and visualized with El-MAVEN (Elucidata) using 5 ppm ion extraction window, minimum peak intensity of 1 x 10^5 ions, and minimum signal to background blank ratio of 2. |
Ion Mode: | POSITIVE |